Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 28, 2026; 32(48): 123033
Published online Dec 28, 2026. doi: 10.3748/wjg.123033
Published online Dec 28, 2026. doi: 10.3748/wjg.123033
Figure 6 Expression levels of the 31 significantly differential metabolites in the three experimental groups (n = 8).
aP < 0.05 vs methionine-choline-sufficient (MCS) group; bP < 0.01 vs MCS group; cP < 0.001 vs MCS group; dP < 0.01 vs methionine-choline-deficient (MCD) group; eP < 0.001 vs MCD group. MCD: Methionine-choline-deficient; MCS: Methionine-choline-sufficient; JQFH: Jiangtang Qingre formula-high.
- Citation: Zhou LJ, Wu JL, Wang H, Han R, Tang C, Fang F, Zhu DP. Integrating proteomics, metabolomics, and molecular docking to elucidate the mechanism of Jiangtang Qingre formula against metabolic dysfunction-associated steatohepatitis. World J Gastroenterol 2026; 32(48): 123033
- URL: https://www.wjgnet.com/1007-9327/full/v32/i48/123033.htm
- DOI: https://dx.doi.org/10.3748/wjg.123033